Post date May 5, 2023 Experience DexCom $1.25 billion convertible notes offering and capped call transactions The 0.375% convertible senior notes are due 2028
Post date December 14, 2022 Experience Priveterra Acquisition initial business combination with AEON Biopharma We are advising Priveterra on the transaction
Post date December 5, 2022 Experience IVERIC bio $324.7 million stock offering The shares are listed on the Nasdaq Global Select Market
Post date August 19, 2022 Experience Freeman Spogli investment in EverVet We advised Tailwind Capital and EverVet on the transaction
Post date June 21, 2022 Experience TPG Capital $1.1 billion take-private acquisition of Convey Health Solutions We are advising TPG Capital on the transaction
Post date April 27, 2022 Experience Ingenovis Health acquisition of VISTA Staffing Solutions We are advising Ingenovis Health, Cornell Capital and Trilantic on the transaction
Post date February 11, 2022 Experience Signify Health $250 million acquisition of Caravan Health We are advising Signify Health on the transaction
Post date January 10, 2022 Experience Convey Health Solutions acquisition of HealthSmart International We are advising Convey Health Solutions on the transaction
Post date November 24, 2021 Experience Privia Health $174 million secondary offering We advised Privia on its SEC-registered offering of stock
Post date November 12, 2021 Experience Cryoport $403 million notes offering and concurrent $249 million stock offering The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering